FEATURED, Research, Genetic Testing, Risk Assessment
Do we now start testing patients who have familial BC but not BRCA 1 or 2?
Four Additional Genes Added to the List of Associated Breast Cancer Risk As we do more and more genetic testing with ever expanding panels, we discover more gen...
FEATURED, Research, Opinion, Genetics
Somatic Cancer Mutations Accrue Over Years But Not All Become Cancer
Still a mystery why certain somatic mutations become cancerous while others don’t: It’s not merely a numbers game When researchers found that ”Somatic mutant ...
FEATURED, Research, Opinion, Genetic Testing, Neoadjuvant Therapy
Broad Implications for Personalized Recurrence Monitoring
A new approach to personalizing detection, monitoring, and delivering cancer treatment The blog below is authored by Peter Beitsch, MD based on a summary articl...
FEATURED, Genetic Testing, Risk Assessment
Is Genetic Testing Ready for PrimeTime?
Should we start using genetics routinely as a screen for early disease prevention? In an editorial by Dr. Kevin Hughes, he points out the dilemma that we have p...
FEATURED, Opinion, Research, Imaging
Does MRI Offer Any Advantage Over Breast Tomography with Ultrasound when Screening for Breast Cancer?
Breast MRI is an accepted screening modality in genetically high-risk women and those whose calculated risk is high, as well as in women with dense breast tissu...
Should Breast Surgery Be Its Own Medical Specialty?
TME Breast Care Network doctor Peter Beitsch was one of the doctors discussing whether or not breast cancer surgery should be a specialty of general surgery. In...
What was the first targeted therapy for breast cancer?
A BRIEF HISTORY OF HER2/NEU Trastuzumab was not the first targeted therapy for breast cancer. It’s likely that the first targeted therapy in modern times was o...
FEATURED, News, Genomics, Radiation, Risk Assessment, Regional Management
Influence of the subtype on local recurrence risk of breast cancer with or without radiotherapy
Breast Cancer Subtype May Be Predictive of Ipsilateral Breast Tumor Recurrence Studies have shown that certain intrinsic subtypes of breast cancer are associate...
FEATURED, News, Genomics, Risk Assessment, Histology
Standard Light Microscopy Illuminates a Molecular Mystery
Why do triple negative breast cancers in BRCA-1 patients have a better prognosis?
